Skip to main content
. 2018 Mar 27;67(8):1663–1672. doi: 10.2337/db17-1449

Table 5.

Ratio of geometric mean ratios (95% CI) of baseline and follow-up insulin, HOMA-IR, and HOMA-B, associated with doubling of sphingomyelin species at different BMIs

BMI (kg/m2)
P for interaction
20 25 30 35 40 45
Baseline insulin
 SM-18
0.80 (0.69–0.91)
0.88 (0.81–0.96)
0.96 (0.89–1.03)
1.03 (0.95–1.12)
1.10 (0.98–1.23)
1.16 (1.00–1.34)
0.0027
 SM-20
0.80 (0.70–0.91)
0.89 (0.82–0.96)
0.97 (0.90–1.04)
1.04 (0.95–1.13)
1.11 (0.99–1.24)
1.17 (1.02–1.35)
0.0011
 SM-22
0.82 (0.72–0.93)
0.92 (0.85–1.00)
1.01 (0.94–1.08)
1.09 (1.00–1.19)
1.17 (1.05–1.31)
1.25 (1.08–1.44)
0.0005
 SM-24
0.76 (0.67–0.86)
0.87 (0.80–0.94)
0.96 (0.90–1.03)
1.06 (0.98–1.14)
1.14 (1.03–1.27)
1.22 (1.07–1.39)
2.7 × 10−5
Follow-up insulin
 SM-18
0.85 (0.69–1.05)
0.96 (0.84–1.09)
1.05 (0.94–1.17)
1.14 (0.99–1.31)
1.23 (1.02–1.47)
1.30 (1.03–1.64)
0.028
 SM-20
0.79 (0.65–0.96)
0.92 (0.81–1.04)
1.05 (0.94–1.17)
1.17 (1.02–1.35)
1.29 (1.07–1.55)
1.41 (1.12–1.77)
0.0020
 SM-22
0.80 (0.65–0.98)
0.94 (0.83–1.07)
1.08 (0.97–1.20)
1.21 (1.05–1.39)
1.34 (1.11–1.61)
1.46 (1.15–1.84)
0.0019
 SM-24
0.76 (0.63–0.93)
0.90 (0.79–1.01)
1.02 (0.92–1.13)
1.14 (1.01–1.30)
1.26 (1.06–1.49)
1.37 (1.10–1.70)
0.0014
Baseline HOMA-IR
 SM-18
0.79 (0.69–0.92)
0.88 (0.81–0.97)
0.96 (0.89–1.04)
1.04 (0.94–1.14)
1.10 (0.98–1.25)
1.17 (1.00–1.36)
0.0039
 SM-20
0.78 (0.68–0.89)
0.88 (0.81–0.96)
0.97 (0.90–1.04)
1.05 (0.96–1.15)
1.13 (1.00–1.27)
1.20 (1.03–1.40)
0.0006
 SM-22
0.81 (0.71–0.93)
0.92 (0.84–1.00)
1.02 (0.95–1.09)
1.11 (1.01–1.21)
1.19 (1.06–1.34)
1.27 (1.09–1.48)
0.0005
 SM-24
0.76 (0.66–0.87)
0.87 (0.80–0.95)
0.97 (0.91–1.04)
1.06 (0.98–1.16)
1.15 (1.03–1.29)
1.24 (1.08–1.42)
5.2 × 10−5
Follow-up HOMA-IR
 SM-18
0.86 (0.69–1.07)
0.96 (0.83–1.10)
1.05 (0.93–1.18)
1.13 (0.98–1.31)
1.21 (0.99–1.47)
1.28 (1.00–1.64)
0.052
 SM-20
0.78 (0.63–0.95)
0.91 (0.80–1.04)
1.04 (0.93–1.17)
1.17 (1.01–1.35)
1.29 (1.06–1.56)
1.40 (1.10–1.79)
0.0030
 SM-22
0.80 (0.64–0.99)
0.94 (0.82–1.07)
1.07 (0.96–1.20)
1.20 (1.04–1.40)
1.33 (1.09–1.62)
1.45 (1.13–1.86)
0.0036
 SM-24
0.77 (0.62–0.94)
0.90 (0.79–1.02)
1.02 (0.92–1.14)
1.14 (1.00–1.31)
1.26 (1.05–1.51)
1.37 (1.09–1.72)
0.0029
Baseline HOMA-B
 SM-18
0.77 (0.68–0.88)
0.86 (0.79–0.93)
0.93 (0.87–1.00)
1.00 (0.92–1.09)
1.07 (0.95–1.19)
1.13 (0.98–1.30)
0.0020
 SM-20
0.84 (0.74–0.95)
0.90 (0.83–0.97)
0.95 (0.88–1.01)
0.99 (0.91–1.08)
1.03 (0.92–1.15)
1.07 (0.93–1.23)
0.033
 SM-22
0.82 (0.72–0.93)
0.90 (0.83–0.98)
0.98 (0.91–1.04)
1.04 (0.96–1.14)
1.11 (0.99–1.24)
1.17 (1.02–1.34)
0.0022
 SM-24
0.75 (0.66–0.84)
0.84 (0.78–0.91)
0.93 (0.87–0.99)
1.01 (0.94–1.09)
1.09 (0.99–1.21)
1.16 (1.02–1.32)
5.3 × 10−5
Follow-up HOMA-B
 SM-18
0.80 (0.67–0.97)
0.93 (0.83–1.05)
1.05 (0.95–1.16)
1.17 (1.03–1.32)
1.27 (1.08–1.51)
1.38 (1.11–1.70)
0.0026
 SM-20
0.81 (0.68–0.97)
0.94 (0.84–1.05)
1.05 (0.95–1.16)
1.16 (1.02–1.31)
1.26 (1.07–1.49)
1.35 (1.10–1.67)
0.0029
 SM-22
0.80 (0.66–0.96)
0.94 (0.84–1.05)
1.07 (0.97–1.18)
1.19 (1.05–1.35)
1.31 (1.11–1.56)
1.43 (1.16–1.77)
0.0009
 SM-24 0.73 (0.61–0.88) 0.87 (0.78–0.97) 1.00 (0.91–1.09) 1.12 (1.00–1.26) 1.24 (1.06–1.45) 1.36 (1.12–1.65) 0.0002